Showing results (171-180 of 350) with videos related to
Sort By:
Pageof 35
Peptides|July 1, 1985
Cholecystokinin octapeptide analogues stable to brain proteolysisM Knight, P Barone, C A Tamminga, et al.Brain Research|September 11, 1995
The cannabinoid agonists WIN 55,212-2 and CP 55,940 attenuate rotational behavior induced by a dopamine D1 but not a D2 agonist in rats with unilateral lesions of the nigrostriatal pathwayL A Anderson, J J Anderson, T N Chase, et al.Life Sciences|January 1, 1990
The effects of striatal lesion on turning behavior and globus pallidus single unit response to dopamine agonist administrationH S Pan, T M Engber, T N Chase, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1989
Selective D-1 dopamine receptor agonist effects in hyperkinetic extrapyramidal disordersA Braun, M M Mouradian, E Mohr, et al.Clinical Pharmacology and Therapeutics|February 1, 1979
Bromocriptine inhibits norepinephrine releaseM G Ziegler, C R Lake, A C Williams, et al.Neurology|June 1, 1986
Familial Tourette's syndrome: report of a large pedigree and potential for linkage analysisR Kurlan, J Behr, L Medved, et al.Neurology|May 1, 1987
3-O-methyldopa and motor fluctuations in Parkinson's diseaseG Fabbrini, J L Juncos, M M Mouradian, et al.Neuroscience|July 1, 1988
The D1 dopamine receptor in the rat brain: quantitative autoradiographic localization using an iodinated ligandT M Dawson, P Barone, A Sidhu, et al.Journal of Neurochemistry|January 26, 2000
Kainic acid-induced apoptosis in rat striatum is associated with nuclear factor-kappaB activationM Nakai, Z H Qin, J F Chen, et al.Neurology|July 1, 1987
Levodopa methyl ester treatment of Parkinson's diseaseJ L Juncos, M M Mouradian, G Fabbrini, et al.Pageof 35